|
CHARMM-GUI: A web-based graphical user interface for CHARMM
|
journal
|
March 2008 |
|
Mutational Impact on “in-Between-Ring” (IBR) Domain of PARKIN on Protein Stability and Function
|
journal
|
January 2021 |
|
Proline kinks in transmembrane α-helices
|
journal
|
April 1991 |
|
A complete immunoglobulin gene is created by somatic recombination
|
journal
|
September 1978 |
|
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH
|
journal
|
April 1980 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
|
journal
|
March 2018 |
|
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
|
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
|
journal
|
February 2017 |
|
Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
|
journal
|
December 2017 |
|
Antibody response to Candida albicans cell wall antigens
|
journal
|
July 2004 |
|
Increasing Protein Conformational Stability by Optimizing β-Turn Sequence
|
journal
|
October 2007 |
|
Virus glycosylation: role in virulence and immune interactions
|
journal
|
May 2007 |
|
The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein
|
journal
|
January 2000 |
|
Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain
|
journal
|
March 1988 |
|
Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility
|
journal
|
April 2008 |
|
The joining of V and J gene segments creates antibody diversity
|
journal
|
January 1980 |
|
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes
|
journal
|
April 1981 |
|
Replacing the complementarity-determining regions in a human antibody with those from a mouse
|
journal
|
May 1986 |
|
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
|
journal
|
April 2016 |
|
Carbohydrate vaccines: developing sweet solutions to sticky situations?
|
journal
|
April 2010 |
|
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region
|
journal
|
November 2010 |
|
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
|
journal
|
May 2013 |
|
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity
|
journal
|
November 2017 |
|
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
|
journal
|
March 2018 |
|
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
|
journal
|
February 2019 |
|
High frequency of shared clonotypes in human B cell receptor repertoires
|
journal
|
February 2019 |
|
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
|
journal
|
September 2010 |
|
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
|
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
|
journal
|
October 2012 |
|
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
|
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
|
journal
|
April 2016 |
|
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment.
|
journal
|
June 1996 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer
|
journal
|
September 2015 |
|
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
|
journal
|
June 2003 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
|
journal
|
October 2011 |
|
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
|
journal
|
July 2014 |
|
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
|
journal
|
March 2017 |
|
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120
|
journal
|
April 2008 |
|
An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies
|
journal
|
July 2008 |
|
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
|
journal
|
August 2010 |
|
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140
|
journal
|
May 2015 |
|
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy
|
journal
|
June 2014 |
|
Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope
|
journal
|
November 2014 |
|
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
|
journal
|
February 2012 |
|
Three-Dimensional Structure of Immunoglobulins
|
journal
|
June 1979 |
|
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
|
journal
|
May 2010 |
|
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors
|
journal
|
January 2013 |
|
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
|
journal
|
August 2011 |
|
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
|
journal
|
May 2009 |
|
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
|
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
|
journal
|
August 2016 |
|
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
|
journal
|
January 2017 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
|
text
|
January 2010 |
|
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard.
|
journalarticle
|
January 2008 |
|
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline
|
journal
|
January 2014 |
|
CHARMM-GUI: A web-based graphical user interface for CHARMM
|
journal
|
March 2008 |
|
Structure validation by Cα geometry: ϕ,ψ and Cβ deviation
|
journal
|
January 2003 |
|
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay
|
book
|
January 2009 |
|
Proline kinks in transmembrane α-helices
|
journal
|
April 1991 |
|
A complete immunoglobulin gene is created by somatic recombination
|
journal
|
September 1978 |
|
An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH
|
journal
|
April 1980 |
|
The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein
|
journal
|
January 2000 |
|
Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells.
|
journal
|
June 1990 |
|
Diversity of oligosaccharide structures on the envelope glycoprotein gp 120 of human immunodeficiency virus 1 from the lymphoblastoid cell line H9. Presence of complex-type oligosaccharides with bisecting N-acetylglucosamine residues.
|
journal
|
May 1990 |
|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
The Mechanism and Regulation of Chromosomal V(D)J Recombination
|
journal
|
April 2002 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
|
journal
|
September 2014 |
|
Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines
|
journal
|
March 2018 |
|
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
|
journal
|
March 2016 |
|
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
|
journal
|
February 2017 |
|
Antibody response to Candida albicans cell wall antigens
|
journal
|
July 2004 |
|
A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
|
journal
|
April 2017 |
|
Inhibition of Mammalian Glycan Biosynthesis Produces Non-self Antigens for a Broadly Neutralising, HIV-1 Specific Antibody
|
journal
|
September 2007 |
|
Increasing Protein Conformational Stability by Optimizing β-Turn Sequence
|
journal
|
October 2007 |
|
Virus glycosylation: role in virulence and immune interactions
|
journal
|
May 2007 |
|
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
|
journal
|
September 2006 |
|
Effects of ammonium sulfate on the unfolding and refolding of the variable and constant fragments of an immunoglobulin light chain
|
journal
|
March 1988 |
|
Glycosylation Site-Specific Analysis of HIV Envelope Proteins (JR-FL and CON-S) Reveals Major Differences in Glycosylation Site Occupancy, Glycoform Profiles, and Antigenic Epitopesʼ Accessibility
|
journal
|
April 2008 |
|
Glycosylation Site-Specific Analysis of Clade C HIV-1 Envelope Proteins
|
journal
|
September 2009 |
|
The joining of V and J gene segments creates antibody diversity
|
journal
|
January 1980 |
|
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes
|
journal
|
April 1981 |
|
Replacing the complementarity-determining regions in a human antibody with those from a mouse
|
journal
|
May 1986 |
|
Antibody neutralization and escape by HIV-1
|
journal
|
March 2003 |
|
Exploiting the defensive sugars of HIV-1 for drug and vaccine design
|
journal
|
April 2007 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
|
journal
|
November 2011 |
|
Structural and genetic basis for development of broadly neutralizing influenza antibodies
|
journal
|
August 2012 |
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
|
journal
|
April 2016 |
|
Carbohydrate vaccines: developing sweet solutions to sticky situations?
|
journal
|
April 2010 |
|
Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region
|
journal
|
November 2010 |
|
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
|
journal
|
May 2013 |
|
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity
|
journal
|
November 2017 |
|
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
|
journal
|
March 2018 |
|
Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
|
journal
|
February 2019 |
|
Commonality despite exceptional diversity in the baseline human antibody repertoire
|
journal
|
January 2019 |
|
High frequency of shared clonotypes in human B cell receptor repertoires
|
journal
|
February 2019 |
|
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
|
journal
|
September 2010 |
|
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
|
journal
|
July 2010 |
|
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
|
journal
|
June 2012 |
|
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
|
journal
|
October 2012 |
|
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
|
Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization
|
journal
|
April 2016 |
|
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment.
|
journal
|
June 1996 |
|
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
|
journal
|
January 2011 |
Evolution of the human ABO polymorphism by two complementary selective pressures
- Seymour, Robert M.; Allan, Martin J.; Pomiankowski, Andrew
-
Proceedings of the Royal Society of London. Series B: Biological Sciences, Vol. 271, Issue 1543
https://doi.org/10.1098/rspb.2004.2674
|
journal
|
May 2004 |
|
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard
|
journal
|
December 2007 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer
|
journal
|
September 2015 |
|
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
|
journal
|
June 2003 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
|
journal
|
October 2011 |
|
Structural Studies of Immunoglobulins
|
journal
|
May 1973 |
|
Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
|
journal
|
July 2014 |
|
Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
|
journal
|
March 2017 |
|
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120
|
journal
|
April 2008 |
|
An Engineered Saccharomyces cerevisiae Strain Binds the Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody 2G12 and Elicits Mannose-Specific gp120-Binding Antibodies
|
journal
|
July 2008 |
|
Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization
|
journal
|
August 2007 |
|
Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
|
journal
|
August 2010 |
|
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140
|
journal
|
May 2015 |
|
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy
|
journal
|
June 2014 |
|
Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions
|
journal
|
September 2010 |
|
Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope
|
journal
|
November 2014 |
|
Two Distinct Broadly Neutralizing Antibody Specificities of Different Clonal Lineages in a Single HIV-1-Infected Donor: Implications for Vaccine Design
|
journal
|
February 2012 |
|
Three-Dimensional Structure of Immunoglobulins
|
journal
|
June 1979 |
|
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
|
journal
|
May 2010 |
|
Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors
|
journal
|
January 2013 |
|
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade
|
journal
|
August 2011 |
|
High-Throughput Profiling of Anti-Glycan Humoral Responses to SIV Vaccination and Challenge
|
journal
|
September 2013 |
|
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
|
journal
|
May 2009 |
|
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
|
journal
|
August 2010 |
|
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
|
journal
|
September 2013 |
|
Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
|
journal
|
August 2016 |
|
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
|
journal
|
January 2017 |
|
Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies
|
journal
|
April 2018 |
|
Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline
|
journal
|
January 2014 |